Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1565
-
Total 13F shares, excl. options
-
991M
-
Shares change
-
-6.01M
-
Total reported value, excl. options
-
$71B
-
Value change
-
-$497M
-
Put/Call ratio
-
1.11
-
Number of buys
-
605
-
Number of sells
-
-883
-
Price
-
$71.61
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2016
1,780 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q4 2016.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,565 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 991M shares
of 1.24B outstanding shares and own 79.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (84.5M shares), STATE STREET CORP (60.4M shares), FMR LLC (39.1M shares), BlackRock Institutional Trust Company, N.A. (36.9M shares), BlackRock Fund Advisors (28.5M shares), Bank of New York Mellon Corp (27.8M shares), Capital Research Global Investors (24.8M shares), JPMORGAN CHASE & CO (21.6M shares), Invesco Ltd. (17.5M shares), and NORTHERN TRUST CORP (16.9M shares).
This table shows the top 1565 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.